HHS logo U.S. Department of Health & Human Services NIH logo National Institutes of Health HOME | Contact Us
National Heart Lung and Blood Institute Logo     GENE THERAPY RESOURCE PROGRAM (GTRP) Header

WHAT IS THE NHLBI GENE THERAPY RESOURCE PROGRAM?

The NHLBI Gene Therapy Resource Program (GTRP) facilitates the translation of gene therapy research into clinical interventions.  The GTRP provides resources for gene therapy research primarily in heart, lung, and blood diseases as reflected in the NHLBI Mission (http://www.nhlbi.nih.gov/about/org/mission.htm).  Requests for resources for gene therapy research that are consistent with the missions of other NIH Institutes may also be considered by the Program. 

Resources are provided in the form of preclinical and clinical-grade vector production, pharmacology/toxicology testing, immunology testing, clinical trials funding assistance, and regulatory support at no cost to the investigator.  Investigators must first receive approval of their Registration with the Program in order to request resources.

The GTRP, directed by the NHLBI Gene Therapy Group, consists of three vector production cores, a pharmacology/toxicology testing core, and a clinical coordinating center.  A Scientific Review Board and Steering Committee review Request for Service Applications and make recommendations to the NHLBI Gene Therapy Group regarding the applications’ scientific merit, feasibility, and compatibility with the Program’s mission.

University of
Pennsylvania


Produces large-,
routine, and small-
scale viral and non-viral based vectors for studies in basic research directed toward clinical applications and provides immunology services

The Children’s Hospital of Philadelphia

Produces scalable
clinical-grade adeno-
associated virus (AAV) vectors for use clinical studies; GMP process-comparable AAV vectors for use in pharmacology
/toxicology studies

Indiana
University


Produces scalable
clinical-grade lentiviral vectors for use in clinical studies; produces GMP process-comparable lentivirus vectors for use in pharmacology
/toxicology studies

Lovelace Biomedical
and Environmental
Research Institute

Performs toxicology testing and bio-distribution studies of vectors in large and small animal models as a prerequisite for use in clinical studies

Social & Scientific
Systems, Inc.


Coordinates RSA process management, Steering Committee management,
regulatory support,
and clinical trials funding assistance

HIGHLIGHTS
Program is renewed through
  May 2017!

  
>Instructions for Submitting
   an RSA


>RSA Review Process

>GTRP Newsletter-Spring 2013
  
INFORMATION CENTER
>NHLBI Home
>FAQ's

>Regulatory Resources
  » Regulatory Guidelines
   » Fundamental Elements in
     Gene Vector Development

>Training Resources

>National Gene Vector
  Biorepository

  » Article - April 2009 Download Adobe PDF Reader

>Center for Fetal Monkey
  Gene Transfer


>Publications and Presentations
  by GTRP Investigators
Download Adobe PDF Reader

>BrIDGs(Bridging Interven
  tional Development Gaps
  - Formerly NIH-RAID)

>Other Resources for Vector    Production
  » Association of Academic
     Biologics Manufacturers


>American Society of Gene &
   Cell Therapy

Privacy Statement | FOIA | Accessibility | Contact Us
National Heart, Lung, and Blood Institute   National Institutes of Health    Department of Health and Human Services    USA.gov